Loading…

MiR-27a-3p promotes the osteogenic differentiation by activating CRY2/ERK1/2 axis

Osteoporosis seriously disturbs the life of people. Meanwhile, inhibition or weakening of osteogenic differentiation is one of the important factors in the pathogenesis of osteoporosis. It was reported that miR-27a-3p reduced the symptoms of osteoporosis. However, the mechanism by which miR-27a-3p i...

Full description

Saved in:
Bibliographic Details
Published in:Molecular medicine (Cambridge, Mass.) Mass.), 2021-04, Vol.27 (1), p.43-43, Article 43
Main Authors: Ren, Li-Rong, Yao, Ru-Bin, Wang, Shi-Yong, Gong, Xiang-Dong, Xu, Ji-Tao, Yang, Kai-Shun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c597t-7abc93d5603cf484e8456ce02d5db344a5505ac32ef56e5173b93838eb0ccea3
cites cdi_FETCH-LOGICAL-c597t-7abc93d5603cf484e8456ce02d5db344a5505ac32ef56e5173b93838eb0ccea3
container_end_page 43
container_issue 1
container_start_page 43
container_title Molecular medicine (Cambridge, Mass.)
container_volume 27
creator Ren, Li-Rong
Yao, Ru-Bin
Wang, Shi-Yong
Gong, Xiang-Dong
Xu, Ji-Tao
Yang, Kai-Shun
description Osteoporosis seriously disturbs the life of people. Meanwhile, inhibition or weakening of osteogenic differentiation is one of the important factors in the pathogenesis of osteoporosis. It was reported that miR-27a-3p reduced the symptoms of osteoporosis. However, the mechanism by which miR-27a-3p in osteogenic differentiation remains largely unknown. To induce the osteogenic differentiation in MC3T3-E1 cells, cells were treated with osteogenic induction medium (OIM). RT-qPCR was used to evaluate the mRNA expression of miR-27a-3p and CRY2 in cells. The protein levels of CRY2, Runt-related transcription factor 2 (Runx2), osteopontin (OPN), osteocalcin (OCN) and the phosphorylation level of extracellular regulated protein kinases (ERK) 1/2 in MC3T3-E1 cells were evaluated by western blotting. Meanwhile, calcium nodules and ALP activity were tested by alizarin red staining and ALP kit, respectively. Luciferase reporter gene assay was used to analyze the correlation between CRY2 and miR-27a-3p. The expression of miR-27a-3p and the phosphorylation level of ERK1/2 were increased by OIM in MC3T3-E1 cells, while CRY2 expression was decreased. In addition, OIM-induced increase of calcified nodules, ALP content and osteogenesis-related protein expression was significantly reversed by downregulation of miR-27a-3p and overexpression of CRY2. In addition, miR-27a-3p directly targeted CRY2 and negatively regulated CRY2. Meanwhile, the inhibitory effect of miR-27a-3p inhibitor on osteogenic differentiation was reversed by knockdown of CRY2 or using honokiol (ERK1/2 signal activator). Furthermore, miR-27a-3p significantly inhibited the apoptosis of MC3T3-E1 cells treated by OIM. Taken together, miR-27a-3p/CRY2/ERK axis plays an important role in osteoblast differentiation. MiR-27a-3p promoted osteoblast differentiation via mediation of CRY2/ERK1/2 axis. Thereby, miR-27a-3p might serve as a new target for the treatment of osteoporosis.
doi_str_mv 10.1186/s10020-021-00303-5
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_54b4ec72c7ef45e28c57a1396a1e2192</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_54b4ec72c7ef45e28c57a1396a1e2192</doaj_id><sourcerecordid>2546218208</sourcerecordid><originalsourceid>FETCH-LOGICAL-c597t-7abc93d5603cf484e8456ce02d5db344a5505ac32ef56e5173b93838eb0ccea3</originalsourceid><addsrcrecordid>eNpdkUtvEzEURkcIRB_wB1igkdh0Y-LXtT0bJBQVWlGEiLphZXk8d1JHk3GwnYr-e0xTKsrKr3OP7vXXNG8Yfc-YUYvMKOWUUM4IpYIKAs-aYwbcEKHAPK97qhVhAOyoOcl5U2kGEl42R0J0lEvBj5vvX8OKcO2I2LW7FLexYG7LDbYxF4xrnINvhzCOmHAuwZUQ57a_a50v4bae5nW7XP3gi_PVF7bgrfsV8qvmxeimjK8f1tPm-tP59fKCXH37fLn8eEU8dLoQ7XrfiQEUFX6URqKRoDxSPsDQCykdAAXnBccRFALTou-EEQZ76j06cdpcHrRDdBu7S2Hr0p2NLtj7i5jW1qUS_IQWZC_Ra-41jhKQGw_aMdEpx5CzjlfXh4Nrt--3OPg6anLTE-nTlznc2HW8tYZq3SlRBWcPghR_7jEXuw3Z4zS5GeM-Ww7MdNpo2lX03X_oJu7TXH-qUlJxZjg1leIHyqeYc8LxsRlG7Z_w7SF8WyO19-FbqEVv_x3jseRv2uI3LqCoeg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2546218208</pqid></control><display><type>article</type><title>MiR-27a-3p promotes the osteogenic differentiation by activating CRY2/ERK1/2 axis</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central Free</source><creator>Ren, Li-Rong ; Yao, Ru-Bin ; Wang, Shi-Yong ; Gong, Xiang-Dong ; Xu, Ji-Tao ; Yang, Kai-Shun</creator><creatorcontrib>Ren, Li-Rong ; Yao, Ru-Bin ; Wang, Shi-Yong ; Gong, Xiang-Dong ; Xu, Ji-Tao ; Yang, Kai-Shun</creatorcontrib><description>Osteoporosis seriously disturbs the life of people. Meanwhile, inhibition or weakening of osteogenic differentiation is one of the important factors in the pathogenesis of osteoporosis. It was reported that miR-27a-3p reduced the symptoms of osteoporosis. However, the mechanism by which miR-27a-3p in osteogenic differentiation remains largely unknown. To induce the osteogenic differentiation in MC3T3-E1 cells, cells were treated with osteogenic induction medium (OIM). RT-qPCR was used to evaluate the mRNA expression of miR-27a-3p and CRY2 in cells. The protein levels of CRY2, Runt-related transcription factor 2 (Runx2), osteopontin (OPN), osteocalcin (OCN) and the phosphorylation level of extracellular regulated protein kinases (ERK) 1/2 in MC3T3-E1 cells were evaluated by western blotting. Meanwhile, calcium nodules and ALP activity were tested by alizarin red staining and ALP kit, respectively. Luciferase reporter gene assay was used to analyze the correlation between CRY2 and miR-27a-3p. The expression of miR-27a-3p and the phosphorylation level of ERK1/2 were increased by OIM in MC3T3-E1 cells, while CRY2 expression was decreased. In addition, OIM-induced increase of calcified nodules, ALP content and osteogenesis-related protein expression was significantly reversed by downregulation of miR-27a-3p and overexpression of CRY2. In addition, miR-27a-3p directly targeted CRY2 and negatively regulated CRY2. Meanwhile, the inhibitory effect of miR-27a-3p inhibitor on osteogenic differentiation was reversed by knockdown of CRY2 or using honokiol (ERK1/2 signal activator). Furthermore, miR-27a-3p significantly inhibited the apoptosis of MC3T3-E1 cells treated by OIM. Taken together, miR-27a-3p/CRY2/ERK axis plays an important role in osteoblast differentiation. MiR-27a-3p promoted osteoblast differentiation via mediation of CRY2/ERK1/2 axis. Thereby, miR-27a-3p might serve as a new target for the treatment of osteoporosis.</description><identifier>ISSN: 1076-1551</identifier><identifier>EISSN: 1528-3658</identifier><identifier>DOI: 10.1186/s10020-021-00303-5</identifier><identifier>PMID: 33902432</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Antibodies ; Apoptosis ; Autophagy ; Binding sites ; Cell cycle ; ERK1/2 pathway ; Kinases ; MicroRNAs ; Mineralization ; miR-27a-3p ; Osteogenic differentiation ; Osteoporosis ; Proteins ; Signal transduction</subject><ispartof>Molecular medicine (Cambridge, Mass.), 2021-04, Vol.27 (1), p.43-43, Article 43</ispartof><rights>2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</rights><rights>The Author(s) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c597t-7abc93d5603cf484e8456ce02d5db344a5505ac32ef56e5173b93838eb0ccea3</citedby><cites>FETCH-LOGICAL-c597t-7abc93d5603cf484e8456ce02d5db344a5505ac32ef56e5173b93838eb0ccea3</cites><orcidid>0000-0002-6828-3719</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2546218208/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2546218208?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33902432$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ren, Li-Rong</creatorcontrib><creatorcontrib>Yao, Ru-Bin</creatorcontrib><creatorcontrib>Wang, Shi-Yong</creatorcontrib><creatorcontrib>Gong, Xiang-Dong</creatorcontrib><creatorcontrib>Xu, Ji-Tao</creatorcontrib><creatorcontrib>Yang, Kai-Shun</creatorcontrib><title>MiR-27a-3p promotes the osteogenic differentiation by activating CRY2/ERK1/2 axis</title><title>Molecular medicine (Cambridge, Mass.)</title><addtitle>Mol Med</addtitle><description>Osteoporosis seriously disturbs the life of people. Meanwhile, inhibition or weakening of osteogenic differentiation is one of the important factors in the pathogenesis of osteoporosis. It was reported that miR-27a-3p reduced the symptoms of osteoporosis. However, the mechanism by which miR-27a-3p in osteogenic differentiation remains largely unknown. To induce the osteogenic differentiation in MC3T3-E1 cells, cells were treated with osteogenic induction medium (OIM). RT-qPCR was used to evaluate the mRNA expression of miR-27a-3p and CRY2 in cells. The protein levels of CRY2, Runt-related transcription factor 2 (Runx2), osteopontin (OPN), osteocalcin (OCN) and the phosphorylation level of extracellular regulated protein kinases (ERK) 1/2 in MC3T3-E1 cells were evaluated by western blotting. Meanwhile, calcium nodules and ALP activity were tested by alizarin red staining and ALP kit, respectively. Luciferase reporter gene assay was used to analyze the correlation between CRY2 and miR-27a-3p. The expression of miR-27a-3p and the phosphorylation level of ERK1/2 were increased by OIM in MC3T3-E1 cells, while CRY2 expression was decreased. In addition, OIM-induced increase of calcified nodules, ALP content and osteogenesis-related protein expression was significantly reversed by downregulation of miR-27a-3p and overexpression of CRY2. In addition, miR-27a-3p directly targeted CRY2 and negatively regulated CRY2. Meanwhile, the inhibitory effect of miR-27a-3p inhibitor on osteogenic differentiation was reversed by knockdown of CRY2 or using honokiol (ERK1/2 signal activator). Furthermore, miR-27a-3p significantly inhibited the apoptosis of MC3T3-E1 cells treated by OIM. Taken together, miR-27a-3p/CRY2/ERK axis plays an important role in osteoblast differentiation. MiR-27a-3p promoted osteoblast differentiation via mediation of CRY2/ERK1/2 axis. Thereby, miR-27a-3p might serve as a new target for the treatment of osteoporosis.</description><subject>Antibodies</subject><subject>Apoptosis</subject><subject>Autophagy</subject><subject>Binding sites</subject><subject>Cell cycle</subject><subject>ERK1/2 pathway</subject><subject>Kinases</subject><subject>MicroRNAs</subject><subject>Mineralization</subject><subject>miR-27a-3p</subject><subject>Osteogenic differentiation</subject><subject>Osteoporosis</subject><subject>Proteins</subject><subject>Signal transduction</subject><issn>1076-1551</issn><issn>1528-3658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkUtvEzEURkcIRB_wB1igkdh0Y-LXtT0bJBQVWlGEiLphZXk8d1JHk3GwnYr-e0xTKsrKr3OP7vXXNG8Yfc-YUYvMKOWUUM4IpYIKAs-aYwbcEKHAPK97qhVhAOyoOcl5U2kGEl42R0J0lEvBj5vvX8OKcO2I2LW7FLexYG7LDbYxF4xrnINvhzCOmHAuwZUQ57a_a50v4bae5nW7XP3gi_PVF7bgrfsV8qvmxeimjK8f1tPm-tP59fKCXH37fLn8eEU8dLoQ7XrfiQEUFX6URqKRoDxSPsDQCykdAAXnBccRFALTou-EEQZ76j06cdpcHrRDdBu7S2Hr0p2NLtj7i5jW1qUS_IQWZC_Ra-41jhKQGw_aMdEpx5CzjlfXh4Nrt--3OPg6anLTE-nTlznc2HW8tYZq3SlRBWcPghR_7jEXuw3Z4zS5GeM-Ww7MdNpo2lX03X_oJu7TXH-qUlJxZjg1leIHyqeYc8LxsRlG7Z_w7SF8WyO19-FbqEVv_x3jseRv2uI3LqCoeg</recordid><startdate>20210426</startdate><enddate>20210426</enddate><creator>Ren, Li-Rong</creator><creator>Yao, Ru-Bin</creator><creator>Wang, Shi-Yong</creator><creator>Gong, Xiang-Dong</creator><creator>Xu, Ji-Tao</creator><creator>Yang, Kai-Shun</creator><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6828-3719</orcidid></search><sort><creationdate>20210426</creationdate><title>MiR-27a-3p promotes the osteogenic differentiation by activating CRY2/ERK1/2 axis</title><author>Ren, Li-Rong ; Yao, Ru-Bin ; Wang, Shi-Yong ; Gong, Xiang-Dong ; Xu, Ji-Tao ; Yang, Kai-Shun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c597t-7abc93d5603cf484e8456ce02d5db344a5505ac32ef56e5173b93838eb0ccea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibodies</topic><topic>Apoptosis</topic><topic>Autophagy</topic><topic>Binding sites</topic><topic>Cell cycle</topic><topic>ERK1/2 pathway</topic><topic>Kinases</topic><topic>MicroRNAs</topic><topic>Mineralization</topic><topic>miR-27a-3p</topic><topic>Osteogenic differentiation</topic><topic>Osteoporosis</topic><topic>Proteins</topic><topic>Signal transduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ren, Li-Rong</creatorcontrib><creatorcontrib>Yao, Ru-Bin</creatorcontrib><creatorcontrib>Wang, Shi-Yong</creatorcontrib><creatorcontrib>Gong, Xiang-Dong</creatorcontrib><creatorcontrib>Xu, Ji-Tao</creatorcontrib><creatorcontrib>Yang, Kai-Shun</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Molecular medicine (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ren, Li-Rong</au><au>Yao, Ru-Bin</au><au>Wang, Shi-Yong</au><au>Gong, Xiang-Dong</au><au>Xu, Ji-Tao</au><au>Yang, Kai-Shun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MiR-27a-3p promotes the osteogenic differentiation by activating CRY2/ERK1/2 axis</atitle><jtitle>Molecular medicine (Cambridge, Mass.)</jtitle><addtitle>Mol Med</addtitle><date>2021-04-26</date><risdate>2021</risdate><volume>27</volume><issue>1</issue><spage>43</spage><epage>43</epage><pages>43-43</pages><artnum>43</artnum><issn>1076-1551</issn><eissn>1528-3658</eissn><abstract>Osteoporosis seriously disturbs the life of people. Meanwhile, inhibition or weakening of osteogenic differentiation is one of the important factors in the pathogenesis of osteoporosis. It was reported that miR-27a-3p reduced the symptoms of osteoporosis. However, the mechanism by which miR-27a-3p in osteogenic differentiation remains largely unknown. To induce the osteogenic differentiation in MC3T3-E1 cells, cells were treated with osteogenic induction medium (OIM). RT-qPCR was used to evaluate the mRNA expression of miR-27a-3p and CRY2 in cells. The protein levels of CRY2, Runt-related transcription factor 2 (Runx2), osteopontin (OPN), osteocalcin (OCN) and the phosphorylation level of extracellular regulated protein kinases (ERK) 1/2 in MC3T3-E1 cells were evaluated by western blotting. Meanwhile, calcium nodules and ALP activity were tested by alizarin red staining and ALP kit, respectively. Luciferase reporter gene assay was used to analyze the correlation between CRY2 and miR-27a-3p. The expression of miR-27a-3p and the phosphorylation level of ERK1/2 were increased by OIM in MC3T3-E1 cells, while CRY2 expression was decreased. In addition, OIM-induced increase of calcified nodules, ALP content and osteogenesis-related protein expression was significantly reversed by downregulation of miR-27a-3p and overexpression of CRY2. In addition, miR-27a-3p directly targeted CRY2 and negatively regulated CRY2. Meanwhile, the inhibitory effect of miR-27a-3p inhibitor on osteogenic differentiation was reversed by knockdown of CRY2 or using honokiol (ERK1/2 signal activator). Furthermore, miR-27a-3p significantly inhibited the apoptosis of MC3T3-E1 cells treated by OIM. Taken together, miR-27a-3p/CRY2/ERK axis plays an important role in osteoblast differentiation. MiR-27a-3p promoted osteoblast differentiation via mediation of CRY2/ERK1/2 axis. Thereby, miR-27a-3p might serve as a new target for the treatment of osteoporosis.</abstract><cop>England</cop><pub>BioMed Central</pub><pmid>33902432</pmid><doi>10.1186/s10020-021-00303-5</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-6828-3719</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1076-1551
ispartof Molecular medicine (Cambridge, Mass.), 2021-04, Vol.27 (1), p.43-43, Article 43
issn 1076-1551
1528-3658
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_54b4ec72c7ef45e28c57a1396a1e2192
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central Free
subjects Antibodies
Apoptosis
Autophagy
Binding sites
Cell cycle
ERK1/2 pathway
Kinases
MicroRNAs
Mineralization
miR-27a-3p
Osteogenic differentiation
Osteoporosis
Proteins
Signal transduction
title MiR-27a-3p promotes the osteogenic differentiation by activating CRY2/ERK1/2 axis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T16%3A40%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MiR-27a-3p%20promotes%20the%20osteogenic%20differentiation%20by%20activating%20CRY2/ERK1/2%20axis&rft.jtitle=Molecular%20medicine%20(Cambridge,%20Mass.)&rft.au=Ren,%20Li-Rong&rft.date=2021-04-26&rft.volume=27&rft.issue=1&rft.spage=43&rft.epage=43&rft.pages=43-43&rft.artnum=43&rft.issn=1076-1551&rft.eissn=1528-3658&rft_id=info:doi/10.1186/s10020-021-00303-5&rft_dat=%3Cproquest_doaj_%3E2546218208%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c597t-7abc93d5603cf484e8456ce02d5db344a5505ac32ef56e5173b93838eb0ccea3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2546218208&rft_id=info:pmid/33902432&rfr_iscdi=true